跳至主要内容
临床试验/NCT04135794
NCT04135794进行中(未招募)不适用

Magnetic Resonance-Guided Adaptive Radiotherapy (MRgART) Using an Integrated Magnetic Resonance Linear Accelerator (MRL)

University Health Network, Toronto1 个研究点 分布在 1 个国家目标入组 377 人开始时间: 2019年12月9日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
377
试验地点
1
主要终点
Complication rates measured using the Common Toxicity Criteria for Adverse Events

研究概览

简要总结

This study is being done to help further understand how MR-guided adaptive RT in conjunction with the Integrated Magnetic Resonance Linear Accelerator (MRL) can improve patient outcomes. This study will include participants who will be receiving radiotherapy using the MRL machine to target their cancer more precisely. Participants will be asked to have a few extra MR scans taken during their RT planning and to complete a few quality of life questionnaires.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients 18 years or older with a diagnosis of cancer, regardless of clinical site or stage
  • Planned to receive a course of MR-guided adaptive RT using the MRL
  • Ability to provide informed consent

排除标准

  • Patients under 18 years old

结局指标

主要结局

Complication rates measured using the Common Toxicity Criteria for Adverse Events

时间窗: Within 3 months of completing treatment

Refine our understanding of clinical scenarios where MRgART with the MRL improves patient outcomes and translate this new knowledge and new treatment approach to widespread clinical practice through the development and validation of efficient, cost-effective treatment processes.

Local, regional and distant tumor control rates

时间窗: Up to 5 years post-radiotherapy

Refine our understanding of clinical scenarios where MRgART with the MRL improves patient outcomes and translate this new knowledge and new treatment approach to widespread clinical practice through the development and validation of efficient, cost-effective treatment processes.

Disease-free and overall survival rates

时间窗: Up to 5 years post-radiotherapy

Refine our understanding of clinical scenarios where MRgART with the MRL improves patient outcomes and translate this new knowledge and new treatment approach to widespread clinical practice through the development and validation of efficient, cost-effective treatment processes.

次要结局

  • Patient experience and anxiety related to MR imaging and adaptive RT with the MR(each ambulatory care and radiation treatment review clinic visit (up to 5 years post treatment))
  • Patient experience and anxiety related to MR imaging and adaptive RT with the MR(Immediately after first MRL treatment visit)
  • Patient experience and anxiety related to MR imaging and adaptive RT with the MR(Immediately after last MRL treatment visit)
  • Patient experience and anxiety related to MR imaging and adaptive RT with the MR(d prior to starting treatment with the MRL, immediately after the last MRL treatment, at the first follow-up visit and annually thereafter during follow-up (up to 5 years post treatment))

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验